Kahn SE, Deanfield JE, Jeppesen OK, Emerson SS, Boesgaard TW, Colhoun HM, et al
Glucagon-Like Peptide-1 (GLP-1) treatment ameliorates cognitive impairment by attenuating arc expression in type 2 diabetic rats
doi: 10.3389/fgene.2022.1009883 Received 02 August 2022 Accepted 15 September 2022 Published 29 September 2022 Volume 13 - 2022 Edited by Ertugrul Filiz, Duzce University, Turkey Reviewed by Farman Ali, Fujian Agriculture and Forestry University, China Ajit Ghosh, Shahjalal University of Science and Technology, Bangladesh Updates Copyright 2022 Duan, Yu, Wang, Fu, Cao, Yang and Ye
Patients who continue with treatment and implement recommended lifestyle adjustments can achieve considerable weight loss over a period of 6 to 12 months or more
In addition, Tirzepatide slows down gastric emptying and assists with appetite suppression, resulting in longer periods of satiation and decreased levels of hunger and cravings